AbbVie Q4 FY25: where the revenue came from and where it went
The whole income statement of AbbVie for this quarter, as one diagram: what earned the revenue, and what it went on.
- Period
- Oct 1 – Dec 31, 2025
- Reported
- Feb 20, 2026
Revenue$16.6B
+10% year over year
Gross profit$12.1B
73% margin
Operating profit$4.5B
27% margin
Net profit$1.8B
11% margin
The numbers
| Item | Value | Share of revenue | Year over year |
|---|---|---|---|
| Revenue | 16.6 | 100% | +10% |
| Cost of revenue | −4.6 | 27% | |
| Gross profit | 12.1 | 73% margin | +2pp |
| SG&A | −3.9 | 23% | −2pp |
| Other | −3.6 | 22% | +0pp |
| Operating profit | 4.5 | 27% margin | +37pp |
| Interest & other costs | −1.9 | ||
| Tax | −0.9 | ||
| Net profit | 1.8 | 11% margin | +11pp |
181 of 418 companies, most recently reported first
New results in your inbox
When a big company reports, we send you a link to its diagram before anyone has time to comment on it. This is a mailing list, not an account: it does not open the diagrams by itself. No spam, one-click unsubscribe.
Drag or use the arrow keys to see the rest